Stool transplant vs standard care for repeated bile duct infections
Treatments studied
Part of Digestive system, Infections clinical trials.
This trial compares a treatment using a stool transplant (from a healthy donor in capsules) to standard care for people who have had at least two bile duct infections in the past year. It aims to see if the stool transplant can prevent future infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had at least 2 episodes of acute bile duct infection (cholangitis) in the past year.
- You can swallow capsules and do not have trouble eating or drinking by mouth.
- You are not pregnant or breastfeeding.
- You do not have other serious illnesses like cancer or organ failure that might limit your life to less than one year.
- Your bile duct blockage is either caused by stones that can be removed, or a narrowing that can be opened with a procedure or stent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how having a bile duct infection affects the timing of replacing plastic stents in patients with jaundice. It may help doctors decide when to change stents to prevent complications.
This trial tests if a fecal microbiota transplant (FMT) can help people with primary sclerosing cholangitis (PSC) and inactive inflammatory bowel disease (IBD). It compares FMT against a placebo to see if it improves liver health.
This trial studies whether fecal microbiota transplantation (a procedure that transfers healthy stool bacteria) can change a person’s gut bacteria after repeated C. difficile infection. It may help reduce recurring infections by restoring a healthier balance of gut microbes.
This trial tests if capsules containing fecal microbiota can prevent further Clostridioides difficile infections in people who have had at least two recurrences. If you've had multiple C. diff infections and your symptoms go away with antibiotics, this treatment might help keep them from coming back.
This trial tests whether a fecal (stool) transplant from a healthy donor can help people with both PSC and inflammatory bowel disease. It aims to see if the treatment can improve liver health and reduce inflammation. You must have early to moderate liver scarring and be on stable medications.
This trial studies fecal microbiota transplantation (a stool-based treatment) to improve symptoms and safety in people with certain gut and immune conditions. It aims to see whether changing gut bacteria can help you feel better.
Hear when a new Recurrence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.